Clinical Trials

12 enrolled

Glioblastoma

NCT04977375 2025-09-03

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

Phase 1/2 Recruiting

10 enrolled

Phase 2 Active not recruiting

Brain Neoplasms, Glioblastoma, Glioma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

NCT04225039 2025-08-15

Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma

39 enrolled 10 charts

Glioblastoma

NCT02186509 2025-04-30

Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas

17 enrolled 11 charts

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT05900908 2025-04-10

PATHWAyS

Phase 4 Withdrawn

Glioblastoma, Neoplasm Metastasis, Neoplasms, Recurrence

NCT02085304 2024-04-19

Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM

Phase 1/2 Terminated

8 enrolled

Glioblastoma

NCT02052648 2024-03-27

Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors

Phase 1/2 Completed

160 enrolled 21 charts

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

NCT04671459 2023-06-28

TaRRGET

Phase 2 Unknown

40 enrolled

Glioblastoma, Recurrence

NCT03055208 2023-05-11

Gamma-GBM

Phase NA Suspended

50 enrolled

Glioblastoma

NCT03956706 2023-03-15

Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas

Phase NA Withdrawn

CNSLymphoid

Astrocytoma, Glioblastoma, Glioma, Lymphoma, Follicular

NCT04205357 2023-03-03

SAS-GKRS

24 enrolled

Glioblastoma, Glioma

NCT05131711 2021-11-23

CSREIG

Phase 1/2 Unknown

60 enrolled

Glioblastoma

NCT01120639 2021-08-06

Tx-Treatment

Phase 1/2 Completed

30 enrolled 19 charts

Brain Neoplasms, Glioblastoma, Neurologic Manifestations

NCT00006386 2020-10-22

Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme

Phase 2 Completed

80 enrolled

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT01392209 2019-11-22

Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma

15 enrolled

Phase EARLY_PHASE1 Terminated

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma

NCT01086345 2018-07-03

Radiosurgery Plus Bevacizumab in Glioblastoma

9 enrolled

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT02648633 2017-05-31

Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma

Phase 1 Terminated

4 enrolled

Brain Neoplasms, Glioblastoma

NCT00456612 2017-03-06

Radiosurgery for Glioblastoma Multiforme

Phase 1/2 Terminated

4 enrolled 3 charts

Glioblastoma

NCT01378481 2014-12-23

High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma

Phase 1 Terminated

30 enrolled

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT00004262 2013-06-04

Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme

12 enrolled

Glioblastoma, Gliosarcoma

NCT01011231 2013-05-06

GKS

Phase 2 Terminated

1 enrolled

Glioblastoma, Glioma

NCT00003916 2012-09-24

Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma

Phase 3 Completed

25 enrolled

Astrocytoma, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00253448 2011-08-29

Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme

Phase 2 Completed

35 enrolled 7 charts